How would you treat lymphoplasmacytic lymphoma (LPL) with a non-IgM paraprotein?
Does your treatment approach differ from Waldenstrom's Macroglobulinemia?
Does the presence/absence of a MYD88 L265P and/or CXCR4 mutation change your treatment approach?
1 Answer
Mednet Member
Medical Oncology · Mayo Clinic
Answered on
My treatment approach would be similar to those with IgM LPL (WM).
Join for free or sign in to see the full answer